Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Astellas Names Government Affairs and Policy VP | Contract Pharma
Promotions & Moves

Astellas Names Government Affairs and Policy VP

Devaney to implement federal and state government strategies in the Americas

Joseph Devaney has been appointed vice president, Government Affairs and Policy, Americas at Astellas. Mr. Devaney will be based in Astellas’ Washington, DC office, reporting to Jeffrey Winton, senior vice president of Corporate Affairs. 
 
Mr. Devaney will be responsible for leading the Government Affairs and Policy team and developing, communicating, and implementing Astellas’ federal and state government strategies, engagement activities and policy development across all functional areas.   
 
Devaney joins the company after 20 years at Sanofi and its predecessor companies, where he held roles of increasing responsibility in public policy and market access, including most recently the role of vice president of Federal and State Relations. Prior to Sanofi, he was director of state government affairs for Sandoz, which became part of Novartis in 1996.   
 
“Joe’s experience and leadership will elevate our highly collaborative team of senior government strategy, policy, legislative and regulatory professionals in Washington, D.C.,” Mr. Winton said. “His role in developing Astellas’ strategy on public policy issues being considered by government lawmakers and trade associations will be pivotal in Astellas’ growth throughout the Americas region.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters